Abstract
A 56 year old postmenopausal patient underwent a right radical mastectomy for a stage I breast cancer. An adjuvant treatment with tamoxifen was planned, but, because of patient's choice, a regular administration of the endocrine treatment started only one year after the operation. After a very short period of drug administration, she developed a steroid responsive nephrotic syndrome. We have reviewed the international literature concerning drug-induced renal disease; this is the first case of a tamoxifen-induced nephrotic syndrome.
| Original language | English |
|---|---|
| Pages (from-to) | 2171-2172 |
| Number of pages | 2 |
| Journal | Anticancer Research |
| Volume | 14 |
| Issue number | 5 B |
| Publication status | Published - 1994 |
Fingerprint
Keywords
- Breast cancer
- Endocrine treatment
- Nephrotic syndrome
ASJC Scopus subject areas
- Cancer Research
- Oncology
Cite this
Nephrotic syndrome and adjuvant treatment with tamoxifen for early breast cancer case report and review of the literature. / Lauro, S.; Lalle, M.; Andrea, M. R D; Vecchione, A.; Frati, L.
In: Anticancer Research, Vol. 14, No. 5 B, 1994, p. 2171-2172.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Nephrotic syndrome and adjuvant treatment with tamoxifen for early breast cancer case report and review of the literature
AU - Lauro, S.
AU - Lalle, M.
AU - Andrea, M. R D
AU - Vecchione, A.
AU - Frati, L.
PY - 1994
Y1 - 1994
N2 - A 56 year old postmenopausal patient underwent a right radical mastectomy for a stage I breast cancer. An adjuvant treatment with tamoxifen was planned, but, because of patient's choice, a regular administration of the endocrine treatment started only one year after the operation. After a very short period of drug administration, she developed a steroid responsive nephrotic syndrome. We have reviewed the international literature concerning drug-induced renal disease; this is the first case of a tamoxifen-induced nephrotic syndrome.
AB - A 56 year old postmenopausal patient underwent a right radical mastectomy for a stage I breast cancer. An adjuvant treatment with tamoxifen was planned, but, because of patient's choice, a regular administration of the endocrine treatment started only one year after the operation. After a very short period of drug administration, she developed a steroid responsive nephrotic syndrome. We have reviewed the international literature concerning drug-induced renal disease; this is the first case of a tamoxifen-induced nephrotic syndrome.
KW - Breast cancer
KW - Endocrine treatment
KW - Nephrotic syndrome
UR - http://www.scopus.com/inward/record.url?scp=0028576899&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028576899&partnerID=8YFLogxK
M3 - Article
C2 - 7840519
AN - SCOPUS:0028576899
VL - 14
SP - 2171
EP - 2172
JO - Anticancer Research
JF - Anticancer Research
SN - 0250-7005
IS - 5 B
ER -